Managers / Q2 2023 · view latest →
Saturn V Capital Management LP
CIK 0001964437 · 919 CONGRESS AVENUE, SUITE 830, AUSTIN, TX, 78701 · 415-738-4435
Reported Value
$180M
Q2 2023
Positions
20
Filings on Record
14
2019–present window
Filed
Aug 14, 2023
original filing
Summary
Saturn V Capital Management Lp reported $180M in U.S.-listed holdings across 20 positions for Q2 2023.
Its largest position, Chinook Therapeutics, represents 11.2% of the portfolio.
Compared with Q1 2023, the fund opened 5 new positions and exited 3.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 89.6% · $161M
- Other · 9.6% · $17M
- ADR · 0.9% · $2M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $552M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $545M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $456M | 17 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $247M | 24 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $198M | 21 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $255M | 24 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $280M | 25 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $265M | 26 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $249M | 21 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $261M | 23 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $239M | 20 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $180M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $134M | 18 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $120.5B | 19 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.